Published in Am J Epidemiol on December 01, 1982
Cholera. Clin Microbiol Rev (1995) 12.33
Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae. Microbiol Mol Biol Rev (1998) 8.36
New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol Rev (1983) 7.16
Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect Immun (1988) 4.44
Attachment of Vibrio cholerae serogroup O1 to zooplankton and phytoplankton of Bangladesh waters. Appl Environ Microbiol (1990) 3.73
Interventions for the control of diarrhoeal diseases among young children: rotavirus and cholera immunization. Bull World Health Organ (1985) 3.59
Detection of Vibrio cholerae O1 in the aquatic environment by fluorescent-monoclonal antibody and culture methods. Appl Environ Microbiol (1990) 3.21
Critical factors influencing the occurrence of Vibrio cholerae in the environment of Bangladesh. Appl Environ Microbiol (2005) 3.17
Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory. J Clin Invest (1991) 2.97
Self-limiting nature of seasonal cholera epidemics: Role of host-mediated amplification of phage. Proc Natl Acad Sci U S A (2005) 2.80
Cholera transmission: the host, pathogen and bacteriophage dynamic. Nat Rev Microbiol (2009) 2.79
The burden of cholera in the slums of Kolkata, India: data from a prospective, community based study. Arch Dis Child (2005) 2.59
Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine. Infect Immun (1984) 2.48
Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh. PLoS Negl Trop Dis (2008) 2.48
Evaluation of the human immune response to outer membrane proteins of Vibrio cholerae. Infect Immun (1984) 2.42
Effects of microcosm salinity and organic substrate concentration on production of Vibrio cholerae enterotoxin. Appl Environ Microbiol (1986) 2.25
Isolation of enterotoxigenic Bacteroides fragilis from Bangladeshi children with diarrhea: a controlled study. J Clin Microbiol (1994) 2.23
The mannose-sensitive hemagglutinin of Vibrio cholerae promotes adherence to zooplankton. Appl Environ Microbiol (2001) 2.23
Toxigenic Vibrio cholerae in the aquatic environment of Mathbaria, Bangladesh. Appl Environ Microbiol (2006) 1.81
Persistence of plasmids, cholera toxin genes, and prophage DNA in classical Vibrio cholerae O1. Infect Immun (1984) 1.79
Ecology of Vibrio cholerae non-O1 and Salmonella spp. and role of zooplankton in their seasonal distribution in Fukuyama coastal waters, Japan. Appl Environ Microbiol (1989) 1.74
Seasonal cholera caused by Vibrio cholerae serogroups O1 and O139 in the coastal aquatic environment of Bangladesh. Appl Environ Microbiol (2006) 1.65
Local and systemic antibody responses and immunological memory in humans after immunization with cholera B subunit by different routes. Bull World Health Organ (1984) 1.62
Clinical outcomes in household contacts of patients with cholera in Bangladesh. Clin Infect Dis (2009) 1.61
Use of in vivo-induced antigen technology (IVIAT) to identify genes uniquely expressed during human infection with Vibrio cholerae. Proc Natl Acad Sci U S A (2003) 1.60
Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh. Infect Immun (2009) 1.56
Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a. Infect Immun (1990) 1.55
Increased levels of inflammatory mediators in children and adults infected with Vibrio cholerae O1 and O139. Clin Diagn Lab Immunol (2002) 1.54
Pathogen adaptation to seasonal forcing and climate change. Proc Biol Sci (2005) 1.40
Spatial dependency of V. cholera prevalence on open space refuse dumps in Kumasi, Ghana: a spatial statistical modelling. Int J Health Geogr (2008) 1.32
Transient transcriptional activation of the Vibrio cholerae El Tor virulence regulator toxT in response to culture conditions. Infect Immun (1999) 1.26
Highly localized sensitivity to climate forcing drives endemic cholera in a megacity. Proc Natl Acad Sci U S A (2012) 1.26
Application of Poisson kriging to the mapping of cholera and dysentery incidence in an endemic area of Bangladesh. Int J Health Geogr (2006) 1.24
Validation of a volunteer model of cholera with frozen bacteria as the challenge. Infect Immun (1998) 1.23
Spatial and demographic patterns of cholera in Ashanti region - Ghana. Int J Health Geogr (2008) 1.23
Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy. PLoS Negl Trop Dis (2012) 1.21
Attenuated live cholera vaccine strain CVD 103-HgR elicits significantly higher serum vibriocidal antibody titers in persons of blood group O. Infect Immun (1995) 1.20
Cholera toxin-specific memory B cell responses are induced in patients with dehydrating diarrhea caused by Vibrio cholerae O1. J Infect Dis (2008) 1.18
Serotype cycles in cholera dynamics. Proc Biol Sci (2006) 1.14
Isolation of Vibrio cholerae O139 synonym Bengal from the aquatic environment in Bangladesh: implications for disease transmission. Appl Environ Microbiol (1994) 1.14
Seasonality of cholera from 1974 to 2005: a review of global patterns. Int J Health Geogr (2008) 1.14
A comparison of clinical and immunologic features in children and older patients hospitalized with severe cholera in Bangladesh. Pediatr Infect Dis J (2008) 1.14
Immune mechanisms and protective antigens of Vibrio cholerae serogroup O139 as a basis for vaccine development. Infect Immun (1996) 1.11
Adoptive transfer of gut mucosal antitoxin memory by isolated B cells 1 year after oral immunization with cholera toxin. Infect Immun (1989) 1.10
Factors that explain excretion of enteric pathogens by persons without diarrhea. Clin Infect Dis (2012) 1.09
Natural cholera infection-derived immunity in an endemic setting. J Infect Dis (2011) 1.09
New-generation vaccines against cholera. Nat Rev Gastroenterol Hepatol (2011) 1.08
Changing epidemiology of cholera due to Vibrio cholerae O1 and O139 Bengal in Dhaka, Bangladesh. Epidemiol Infect (1996) 1.07
In vitro susceptibility of pathogenic Vibrio species to norfloxacin and six other antimicrobial agents. Antimicrob Agents Chemother (1985) 1.02
Spatial clustering in the spatio-temporal dynamics of endemic cholera. BMC Infect Dis (2010) 1.01
Mucosal immunologic responses in cholera patients in Bangladesh. Clin Vaccine Immunol (2011) 1.01
Vibrio cholerae: lessons for mucosal vaccine design. Expert Rev Vaccines (2011) 1.00
Cloning and sequencing of the genes downstream of the wbf gene cluster of Vibrio cholerae serogroup O139 and analysis of the junction genes in other serogroups. Infect Immun (1999) 0.99
Cholera caused by Vibrio cholerae O1 induces T-cell responses in the circulation. Infect Immun (2009) 0.99
Memory T-cell responses to Vibrio cholerae O1 infection. Infect Immun (2009) 0.99
Clonal transmission, dual peak, and off-season cholera in Bangladesh. Infect Ecol Epidemiol (2011) 0.97
Outbreak of human calicivirus gastroenteritis in a day-care center in Sydney, Australia. J Clin Microbiol (1991) 0.97
Immune responses to cholera in children. Expert Rev Anti Infect Ther (2012) 0.93
Antibody-secreting cell responses after Vibrio cholerae O1 infection and oral cholera vaccination in adults in Bangladesh. Clin Vaccine Immunol (2013) 0.92
Vaccines in the time of cholera. Proc Natl Acad Sci U S A (2011) 0.90
Culture adaptation and characterization of group A rotaviruses causing diarrheal illnesses in Bangladesh from 1985 to 1986. J Clin Microbiol (1991) 0.90
Role of Shrimp Chitin in the Ecology of Toxigenic Vibrio cholerae and Cholera Transmission. Front Microbiol (2012) 0.89
Role of zooplankton diversity in Vibrio cholerae population dynamics and in the incidence of cholera in the Bangladesh Sundarbans. Appl Environ Microbiol (2011) 0.87
Hydrocortisone modulates cholera toxin endocytosis by regulating immature enterocyte plasma membrane phospholipids. Gastroenterology (2008) 0.87
Human immune response to Vibrio cholerae O1 whole cells and isolated outer membrane antigens. Infect Immun (1989) 0.87
Importance of cholera and other etiologies of acute diarrhea in post-earthquake Port-au-Prince, Haiti. Am J Trop Med Hyg (2014) 0.86
Risk factors for severe cholera among children under five in rural and urban Bangladesh, 2000-2008: a hospital-based surveillance study. PLoS One (2013) 0.85
Dientamoeba fragilis in Denmark: epidemiological experience derived from four years of routine real-time PCR. Eur J Clin Microbiol Infect Dis (2013) 0.85
Antibiotics for the treatment of Cholera, Shigella and Cryptosporidium in children. BMC Public Health (2013) 0.84
Epidemic cholera spreads like wildfire. Sci Rep (2014) 0.81
Changes in human ecology and behavior in relation to the emergence of diarrheal diseases, including cholera. Proc Natl Acad Sci U S A (1994) 0.81
Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera. Bull World Health Organ (1998) 0.80
Antimicrobial drugs for treating cholera. Cochrane Database Syst Rev (2014) 0.79
Frequency of reexposure to Vibrio cholerae O1 evaluated by subsequent vibriocidal titer rise after an episode of severe cholera in a highly endemic area in Bangladesh. Am J Trop Med Hyg (2012) 0.78
Risk factors for diarrhea hospitalization in Bangladesh, 2000-2008: a case-case study of cholera and shigellosis. BMC Infect Dis (2014) 0.77
Evaluation and use of surveillance system data toward the identification of high-risk areas for potential cholera vaccination: a case study from Niger. BMC Res Notes (2012) 0.76
Using health and demographic surveillance for the early detection of cholera outbreaks: analysis of community- and hospital-based data from Matlab, Bangladesh. Glob Health Action (2016) 0.75
Cholera Outbreaks in Urban Bangladesh In 2011. Epidemiology (Sunnyvale) (2013) 0.75
Antibody avidity in humoral immune responses in Bangladeshi children and adults following administration of an oral killed cholera vaccine. Clin Vaccine Immunol (2013) 0.75
Weak serum and intestinal antibody responses to Vibrio cholerae soluble hemagglutinin in cholera patients. Infect Immun (1984) 0.75
Safety of the oral cholera vaccine in pregnancy: Retrospective findings from a subgroup following mass vaccination campaign in Dhaka, Bangladesh. Vaccine (2017) 0.75
Disease caused by a marine Vibrio. Clinical characteristics and epidemiology. N Engl J Med (1979) 10.57
Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol (1990) 10.23
The diarrheal response of humans to some classic serotypes of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor. J Infect Dis (1985) 9.18
Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol (1992) 8.25
The magnitude of the global problem of acute diarrhoeal disease: a review of active surveillance data. Bull World Health Organ (1982) 7.88
Detection of an adherence factor of enteropathogenic Escherichia coli with a DNA probe. J Infect Dis (1985) 7.78
Ecological relationships between Vibrio cholerae and planktonic crustacean copepods. Appl Environ Microbiol (1983) 7.52
New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol Rev (1983) 7.16
Cholera--a possible endemic focus in the United States. N Engl J Med (1980) 6.71
Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N Engl J Med (1976) 6.52
Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics (2001) 5.58
Epidemic Yersinia enterocolitica infection due to contaminated chocolate milk. N Engl J Med (1978) 5.39
GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology (1995) 5.34
Molecular epidemiology of "Norwalk-like viruses" in outbreaks of gastroenteritis in the United States. J Infect Dis (1998) 5.32
Enzyme-linked immunosorbent assay for detection of Escherichia coli heat-labile enterotoxin. J Clin Microbiol (1977) 5.17
Cholera and other vibrioses in the United States. N Engl J Med (1985) 5.17
The magnitude of the global problem of diarrhoeal disease: a ten-year update. Bull World Health Organ (1992) 5.03
Influence of water temperature, salinity, and pH on survival and growth of toxigenic Vibrio cholerae serovar 01 associated with live copepods in laboratory microcosms. Appl Environ Microbiol (1984) 4.87
Structural interventions in public health. AIDS (2000) 4.86
Ethics and international research. BMJ (1997) 4.70
Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. Zinc Investigators' Collaborative Group. J Pediatr (1999) 4.57
Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect Immun (1988) 4.44
Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems. J Virol (1999) 4.32
Exclusive breastfeeding reduces acute respiratory infection and diarrhea deaths among infants in Dhaka slums. Pediatrics (2001) 4.05
A two-year study of bacterial, viral, and parasitic agents associated with diarrhea in rural Bangladesh. J Infect Dis (1980) 3.96
Identification of a distinct common strain of "Norwalk-like viruses" having a global distribution. J Infect Dis (1999) 3.88
Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: pooled analysis of randomized controlled trials. Am J Clin Nutr (2000) 3.77
Surveillance of patients attending a diarrhoeal disease hospital in Bangladesh. Br Med J (Clin Res Ed) (1982) 3.75
Handwashing to prevent diarrhea in day-care centers. Am J Epidemiol (1981) 3.75
Detection and differentiation of antigenically distinct small round-structured viruses (Norwalk-like viruses) by reverse transcription-PCR and southern hybridization. J Clin Microbiol (1995) 3.69
Rotavirus infections in infants as protection against subsequent infections. N Engl J Med (1996) 3.61
Duration of infection-derived immunity to cholera. J Infect Dis (1981) 3.60
Characterization of rotavirus strains from newborns in New Delhi, India. J Clin Microbiol (1994) 3.50
Validation of postmortem interviews to ascertain selected causes of death in children. Int J Epidemiol (1990) 3.42
Meta-analysis of intervention trials on case-management of pneumonia in community settings. Lancet (1992) 3.38
Enterotoxigenic Escherichia coli and Reovirus-like agent in rural Bangladesh. Lancet (1976) 3.38
Laboratory investigation of diarrhea in travelers to Mexico: evaluation of methods for detecting enterotoxigenic Echerichia coli. J Clin Microbiol (1976) 3.34
Typing of human astroviruses from clinical isolates by enzyme immunoassay and nucleotide sequencing. J Clin Microbiol (1995) 3.30
Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae. J Infect Dis (1982) 3.28
Diarrhoea associated with heat-stable enterotoxin-producing strains of Escherichia coli. Lancet (1975) 3.27
Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development. J Infect Dis (1996) 3.20
Taxonomy and description of Vibrio fluvialis sp. nov. (synonym group F vibrios, group EF6). J Appl Bacteriol (1981) 3.13
Effect of El Niño and ambient temperature on hospital admissions for diarrhoeal diseases in Peruvian children. Lancet (2000) 3.11
Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med (1999) 3.11
The impact of including husbands in antenatal health education services on maternal health practices in urban Nepal: results from a randomized controlled trial. Health Educ Res (2006) 3.10
Giardiasis in day-care centers: evidence of person-to-person transmission. Pediatrics (1977) 3.06
Isolation of Campylobacter fetus subsp. jejuni from Bangladeshi children. J Clin Microbiol (1980) 2.92
Rates, timing and causes of neonatal deaths in rural India: implications for neonatal health programmes. Bull World Health Organ (2006) 2.90
Rotavirus. Emerg Infect Dis (1999) 2.90
Zinc supplementation in young children with acute diarrhea in India. N Engl J Med (1995) 2.89
Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA (1998) 2.86
Field trial of oral cholera vaccines in Bangladesh. Lancet (1986) 2.85
Scombroid fish poisoning. Outbreak traced to commercially canned tuna fish. JAMA (1974) 2.84
Group F, a new Vibrio? Lancet (1977) 2.79
Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection. J Infect Dis (1985) 2.78
RNA sequence of astrovirus: distinctive genomic organization and a putative retrovirus-like ribosomal frameshifting signal that directs the viral replicase synthesis. Proc Natl Acad Sci U S A (1993) 2.77
Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995: surveillance based on the new ICD-9-CM rotavirus-specific diagnostic code. J Infect Dis (1998) 2.75
Malnutrition as an underlying cause of childhood deaths associated with infectious diseases in developing countries. Bull World Health Organ (2000) 2.74
Global seasonality of rotavirus infections. Bull World Health Organ (1990) 2.73
Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994. Am J Obstet Gynecol (1998) 2.72
Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics (2000) 2.71
Coproexamination for botulinal toxin and clostridium botulinum. A new procedure for laboratory diagnosis of botulism. JAMA (1977) 2.71
Correlation of patient immune responses with genetically characterized small round-structured viruses involved in outbreaks of nonbacterial acute gastroenteritis in the United States, 1990 to 1995. J Med Virol (1997) 2.70
Exposure of humans to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in the lung. Am J Respir Cell Mol Biol (1991) 2.67
Enzyme-linked immunosorbent assay to measure antibodies to purified heat-labile enterotoxins from human and porcine strains of Escherichia coli and to cholera toxin: application in serodiagnosis and seroepidemiology. J Clin Microbiol (1985) 2.66
Longitudinal studies of infectious diseases and physical growth of children in rural Bangladesh. II. Incidence of diarrhea and association with known pathogens. Am J Epidemiol (1982) 2.65
Incidence and severity of rotavirus and Escherichia coli diarrhoea in rural Bangladesh. Implications for vaccine development. Lancet (1981) 2.65
The incidence of Vibrio cholerae in water, animals and birds in Kent, England. J Appl Bacteriol (1982) 2.61
Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial. J Infect Dis (1988) 2.57
Methodological issues in diarrhoeal diseases epidemiology: definition of diarrhoeal episodes. Int J Epidemiol (1991) 2.56
Improved thin-layer chromatographic method for the separation of major phospholipids and glycolipids from plant lipid extracts and phosphatidyl glycerol and bis(monoacylglyceryl) phosphate from animal lipid extracts. J Chromatogr (1977) 2.55
Cold weather seasonality of gastroenteritis associated with Norwalk-like viruses. J Infect Dis (2000) 2.54
Causes of childhood deaths in Bangladesh: results of a nationwide verbal autopsy study. Bull World Health Organ (1998) 2.53
Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes. J Immunol (1988) 2.52
Predisposition for cholera of individuals with O blood group. Possible evolutionary significance. Am J Epidemiol (1985) 2.49
Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine. Infect Immun (1984) 2.48
Cholera on Guam, 1974: epidemiologic findings and isolation of non-toxinogenic strains. Am J Epidemiol (1977) 2.46
Ecology of Vibrio species, including Vibrio cholerae, in natural waters in Kent, England. J Appl Bacteriol (1982) 2.45
Unusual diversity of human rotavirus G and P genotypes in India. J Clin Microbiol (1996) 2.43
Effects of diarrhea associated with specific enteropathogens on the growth of children in rural Bangladesh. Pediatrics (1984) 2.37
Detection of group B and C rotaviruses by polymerase chain reaction. J Clin Microbiol (1991) 2.36
Listeria and gram-negative bacillary meningitis in New York City, 1972-1979. Frequent causes of meningitis in adults. Am J Med (1981) 2.36
Zinc supplementation in infants born small for gestational age reduces mortality: a prospective, randomized, controlled trial. Pediatrics (2001) 2.36
Cytotoxicity and induction of proinflammatory cytokines from human monocytes exposed to fine (PM2.5) and coarse particles (PM10-2.5) in outdoor and indoor air. Toxicol Appl Pharmacol (1999) 2.36
Rapid assessment of health status and preventive-medicine needs of newly arrived Kampuchean refugees, Sa Kaeo, Thailand. Lancet (1980) 2.34
Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial. Pediatrics (2001) 2.34
Rotavirus G and P types in children with acute diarrhea in Blantyre, Malawi, from 1997 to 1998: predominance of novel P[6]G8 strains. J Med Virol (1999) 2.33